Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model. (2018)

First Author: Hamilton P

Attributed to: Understanding the autoimmune mechanism in idiopathic membranous nephropathy (IMN) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ndt/gfy049

PubMed Identifier: 29617884

Publication URI: http://europepmc.org/abstract/MED/29617884

Type: Journal Article/Review

Volume: 33

Parent Publication: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Issue: 12

ISSN: 0931-0509